Drug Trials Snapshot: LIVMARLI

LIVMARLI is a drug for the treatment of itching (pruritus) due to blockage of bile flow out of the liver (cholestasis) in patients with Alagille syndrome (ALGS) one year of age and older.

Source: FDA Center for Drug Evaluation and Research - What's New - October 4, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news